TriSalus Life Sciences, Inc. Common Stock (NASDAQ: TLSI) last traded at $5.27, up 0.76% on the session. The quote above updates while this page is open; the figures below are drawn from TriSalus Life Sciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
TriSalus Life Sciences, Inc. Common Stock trades on NASDAQ under the ticker TLSI. Its market capitalisation is $324.50 million.
Valuation measures for TriSalus Life Sciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $324.50M |
|---|---|
| Enterprise value | $334.11M |
| Price / sales | 7.20 |
| Price / book | 49.54 |
| Beta | 1.22 |
Trailing-twelve-month figures tagged in TriSalus Life Sciences, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $45.08M |
|---|---|
| Net income (TTM) | -$28.21M |
| Gross margin | 85.79% |
| Operating margin | -67.68% |
| Return on equity | -430.72% |
| Cash | $46.29M |
Range and volume for TLSI over the past 52 weeks.
| 52-week high | $7.95 |
|---|---|
| 52-week low | $2.20 |
| Volume | 94.1K |
| Average volume | 319.2K |
| Previous close | $5.23 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.